Pembrolizumab, Ctx-471
Mesothelioma, Locally Advanced Solid Tumor, Metastatic Cancer, Head And Neck Cancer, Non-small Cell Lung Cancer, Melanoma, Small Cell Lung Cancer
Completed
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
―